1. Home
  2. TKLF vs EVGN Comparison

TKLF vs EVGN Comparison

Compare TKLF & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

HOLD

Current Price

$2.25

Market Cap

9.4M

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.74

Market Cap

9.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKLF
EVGN
Founded
2006
1999
Country
Japan
Israel
Employees
N/A
N/A
Industry
Other Specialty Stores
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
9.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
TKLF
EVGN
Price
$2.25
$0.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
7.3K
41.9K
Earning Date
12-19-2025
05-20-2026
Dividend Yield
10.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
$2.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$0.72
52 Week High
$4.32
$2.42

Technical Indicators

Market Signals
Indicator
TKLF
EVGN
Relative Strength Index (RSI) 43.83 39.31
Support Level $2.06 $0.73
Resistance Level $2.38 $0.86
Average True Range (ATR) 0.16 0.06
MACD 0.00 -0.00
Stochastic Oscillator 28.09 16.00

Price Performance

Historical Comparison
TKLF
EVGN

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: